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ART ICLE Open Ac ce s s
Zika virus shedding in the stool and
infection through the anorectal mucosa in
mice
Chunfeng Li1,2,3, Yong-Qiang Deng2,4, Shulong Zu5,6, Natalie Quanquin7, Jingzhe Shang1,3, Min Tian2, Xue Ji2,
Na-Na Zhang2, Hao-Long Dong2, Yan-Peng Xu2, Ling-Zhai Zhao4, Fu-Chun Zhang4, Xiao-Feng Li2, Aiping Wu1,3,
Genhong Cheng1,3,7 and Cheng-Feng Qin2,4
Abstract
Zika virus (ZIKV) has elicited global concern due to its unique biological features, unusual transmission routes, and
unexpected clinical outcomes. Although ZIKV transmission through anal intercourse has been reported in humans, it
remains unclear if ZIKV is detectable in the stool, if it can infect the host through the anal canal mucosa, and what the
pathogenesis of such a route of infection might be in the mouse model. Herein, we demonstrate that ZIKV RNA can be
recovered from stools in multiple mouse models, as well as from the stool of a ZIKV patient. Remarkably, intra-anal (i.a.)
inoculation with ZIKV leads to efficient infection in both Ifnar1−/− and immunocompetent mice, characterized by
extensive viral replication in the blood and multiple organs, including the brain, small intestine, testes, and rectum, as
well as robust humoral and innate immune responses. Moreover, i.a. inoculation of ZIKV in pregnant mice resulted in
transplacental infection and delayed fetal development. Overall, our results identify the anorectal mucosa as a
potential site of ZIKV infection in mice, reveal the associated pathogenesis of i.a. infection, and highlight the
complexity of ZIKV transmission through anal intercourse.
Introduction
Zika virus (ZIKV), a flavivirus that resurged in recent
outbreaks in the Americas, was first isolated from a
monkey in the Zika forest of Uganda in 19471. After the
first confirmed human infection in 19642, ZIKV spread
silently through Africa and Asia over the next 40 years.
The first reported outbreak of ZIKV was on Yap Island in
2007, followed by a severe epidemic in 2013 in French
Polynesia, where there was an increased incidence of
Guillain-Barré syndrome (GBS) noted in ZIKV-positive
cases3. The ZIKV outbreak that began in Brazil in 2015
was associated with severe birth defects such as micro-
cephaly, which was later confirmed in both animal models
and clinical investigations4–7.
Similar to other related flaviviruses, such as dengue
virus (DENV) and yellow fever virus (YFV), ZIKV is pri-
marily transmitted through the bite of infected Aedes
mosquitoes8. Interestingly, ZIKV has also been detected
in semen9 and the vaginal swabs of pregnant women10.
This would explain the reported cases of sexual trans-
mission in humans11. Among these cases, ZIKV was pri-
marily transmitted from infected males to uninfected
females12–14, however, there was one case of transmission
from an infected man to his uninfected male partner
through anal intercourse15. Unprotected anal intercourse
is the mode of transmission for ~7.4% of all human
sexually transmitted infections14, which supports the
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possibility that the anorectal mucosa serves as an entry
site for ZIKV infection.
Duggal et al. observed that ZIKV could be transmitted
efficiently through male-to-female intercourse in an
immunodeficient mouse model, as the virus is shed for
prolonged periods in the seminal fluid16. Furthermore,
Yockey et al. found that ZIKV intravaginal infection of
pregnant mice, even in immunocompetent mouse strains,
can lead to in utero infection of the offspring17. These
findings indicate that the vaginal tract mucosa can serve
as an entry site for ZIKV infection. However, whether the
anorectal mucosa can also support viral replication, and
the potential systemic effects from that infection, remain
largely unknown.
ZIKV is also unique among flaviviruses in that high
concentrations are present in multiple secretions and
body fluids of an infected host. In guinea pigs and mon-
keys, intranasal inoculation with ZIKV leads to systemic
infection. Interestingly, even close contact is sufficient for
ZIKV to be transmitted between guinea pigs18. This can
be partially explained by the fact that ZIKV is detectable
in the saliva and tears of humans, monkeys, and guinea
pigs18–20. ZIKV can also be isolated from the urine and
breast milk21,22. However, whether ZIKV can be recov-
ered from fecal specimens needs to be investigated.
In this study, we show that ZIKV can be detected in the
feces of infected mice and a human, suggesting that stool
samples could be used for surveillance of ZIKV infection
in humans or sentinel animals. Importantly, ZIKV can
infect mice through the anorectal mucosa to cause vir-
emia with subsequent testicular damage in ZIKV-infected
male Ifnar1−/− mice, as well as congenital defects in the
offspring of wild-type pregnant C57BL/6 (C57) mice
treated with anti-Ifnar1 antibody. This work describes a
novel mouse model for examining an under-studied route
of ZIKV transmission and pathogenesis.
Results
ZIKV is shed into the stool of infected mice
To assess whether ZIKV is shed into the stool of an
infected host, we initially selected Ifnar1−/− mice as a
well-established model of ZIKV infection23. DENV, a
closely related flavivirus, was also tested for comparison
(Fig. 1a). Upon intraperitoneal (i.p.) infection with a
contemporary Asian strain of ZIKV (GZ01, 105 PFU/
mouse), all Ifnar1−/− mice developed sustained viremia,
with peak titers at 3 days post-infection (dpi) (Fig. 1b).
The average and peak viremia levels in DENV-infected
mice were much lower than what was measured in ZIKV-
infected mice (Fig. 1b). Elevated levels of ZIKV RNA were
also detected in the anal lavage fluid and fecal samples of
ZIKV-infected animals, even at 7 dpi (Fig. 1c, d).
Remarkably, DENV RNA was not detected in either anal
lavage or fecal specimens (Fig. 1c, d). When we repeated
this experiment using another historical ZIKV strain,
FSS13025, viral RNA was also detected in the feces and
anal lavage fluid (Fig. S1). The viral genome could be
amplified from the fecal sample by RT-PCR, and routine
sequencing did not identify any meaningful nucleotide
variations (data not shown). Furthermore, consistent with
previous findings23, both ZIKV and DENV could be
detected in all tested organs at 5 dpi when infection
occurred by the i.p. route (Fig. S2). Interestingly, ZIKV
and DENV RNA were abundant in the small intestine and
rectum (Fig. S2).
We next tested whether ZIKV could also be recovered
from the feces of an infected immunocompetent strain of
mice. As previously described24, C57 mice pretreated with
Fig. 1 ZIKV is shed into the feces of infected Ifnar1−/− mice a Experimental outline for ZIKV infection. Mice were infected with 105 PFU of either
ZIKV (GZ01 strain) or DENV-2 (43 strain) by the i.p. route. b–d RNA in the sera (b), anal lavage fluid (c), and feces (d) from ZIKV- or DENV-infected
Ifnar1−/− mice was analyzed at the indicated time points by qRT-PCR using primers specific for each virus. (n ≥ 5 per group)
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anti-Ifnar1 antibody for 12 h were subsequently infected
with ZIKV strain GZ01 (106 PFU/mouse) by the i.p. route.
Sustained viremia was readily detected at 1, 3, 5, and 7 dpi,
at which time viral RNA was also detectable in both the anal
lavage fluid and feces, albeit at a lower magnitude (Fig. 2a).
We then tested whether C57 mice that were not pretreated
with anti-Ifnar1 antibody25 had similar results. ZIKV RNA
was measurable in both the blood and anal lavage fluid at 1
and 2 dpi, while virus was only detected in the feces at 1 dpi
(Fig. 2b). To support our findings, we were fortunate to
obtain a stool sample from one patient22 during the acute
period of ZIKV infection. A qRT-PCR assay of the sample
showed high levels of ZIKV RNA (~2 × 105 copies/g) 3 days
after the onset of fever, when urine samples were also
positive for ZIKV RNA22. ZIKV infection triggered the
upregulation of multiple cytokines in humans during acute
phase of infection that we were able to characterize by
Luminex assay, including IP-10, IL-5, GM-CSF, TNF-α, IL-
15, IL-10, MIP-1α, IFN-γ, IL-6, IL-1RA, IL-2, MIG, IFN-α,
IL-2R, and IL-4 (Fig. S3). Altogether, our studies confirm
that ZIKV is shed into the feces of both mouse models and
humans during active infection.
ZIKV intra-anal inoculation leads to systemic infection in
mice
The excretion of ZIKV into the feces also highlights the
potential risk of ZIKV transmission through anal inter-
course. We sought to clarify whether the anorectal
mucosa of mice could serve as an entry site for ZIKV
infection. We injected Ifnar1−/− mice by the intra-anal
(i.a.) route with ZIKV strain GZ01 (106 PFU/mouse)22
(Fig. 3a). All infected mice developed the characteristic
symptoms of ZIKV systemic infection, including weight
loss beginning at 6 dpi (Fig. S4a) followed by inactivity,
encephalitis, hindlimb paralysis (Fig. S4b), and death
between 8–18 dpi (Fig. 3b). To examine the lethality of
ZIKV infection when the virus was administered by the i.
a. route, we infected Ifnar1−/− mice with 104 or 105 PFU
doses. The results indicate mortality rates of 20 and 67%
at 104 and 105 PFU, respectively (Fig. S5a). Even at 104
PFU, the virus could be recovered from the serum and all
tested organs, suggesting that i.a. infection with ZIKV is
highly efficient in Ifnar1−/− mice (Fig. S5b, c). ZIKV
infection through the i.a. route resulted in detectable
viremia at 1 dpi, which peaked at 3 dpi before falling at 5
to 7 dpi (Fig. 3c). To identify the tissue tropisms for ZIKV
when transmitted by the i.a. route, multiple organs were
collected at 2, 5, and 12 dpi and subjected to qRT-PCR
analysis. As shown in Fig. 3d, ZIKV RNA was detected in
all tested organs, including the brain, lung, liver, kidney,
spleen, small intestine, testes, and rectum. Interestingly,
ZIKV RNA levels in the brain and testes continued to
increase until 12 dpi, while the levels peaked at 5 dpi in
other organs. At early time points (2 dpi), ZIKV was at its
highest levels in the spleen and rectum. By 5 dpi, the level
in the testes had risen significantly, surpassing the level in
the spleen and rectum, where the levels began to drop.
Although not reaching the high levels seen in the testes,
the ZIKV burden in the brain continued to rise through
day 12 (Fig. 3d). Plaque assays with tissue homogenates
collected at 5 dpi showed the presence of high con-
centrations of infectious ZIKV (Fig. S6a). Interestingly, we
were also able to establish ZIKV infection by the i.p. route
in naive Ifnar1−/− mice using the rectal wash fluid from i.
Fig. 2 ZIKV is shed into the feces of infected immunocompetent mice a–b 3–4-week-old C57 mice were pretreated with anti-Ifnar1 antibody
(a) or mock-treated (b) for 12 h and then infected with ZIKV (GZ01 strain, 106 PFU/mouse) by the i.p. route. ZIKV RNA copies in the blood, anal lavage
and feces at the indicated times were quantified by qRT-PCR (n= 4 per group)
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a.-infected mice at 5 dpi, confirming the prolonged pre-
sence of infectious ZIKV in the anorectal environment.
The recipient mice died by 10 dpi, with viremia from 1 to
8 dpi that peaked at 3 dpi (Fig. S6b, c).
ZIKV infection by the i.p. route has been shown to lead to
testicular damage and infertility in mouse models26,27. Simi-
larly, we noted that the testes of mice infected by the i.a.
route with ZIKV were much smaller than those of mock-
infected mice at 15 dpi (Fig. 3e). Furthermore, H&E staining
revealed severe damage to the structure of the testes, with
Leydig cell fibrosis in ZIKV-infected mice (Fig. S7). ZIKV
infection was similarly associated with inflammatory cell
infiltration and vascular cuffing in the mouse brain and mild
inflammation in the rectum (Fig. S7). More importantly, our
RNA scope assay showed that ZIKV RNA was present in the
testes, brain, rectum, lung, kidney, and small intestine at 5
dpi, but not in mock-infected samples (Fig. 3f). Interestingly,
ZIKV-specific RNA was found in the Leydig cells of the
testes, which is in agreement with previous findings in guinea
pigs and mice18,26.
Fig. 3 ZIKV intra-anal inoculation leads to systemic infection in mice a Illustration of the experiment. 3–4-week-old male Ifnar1−/− mice were
infected with ZIKV (106 PFU/mouse) by the i.a. route (a–f). b The survival rate of the infected Ifnar1−/− mice (n= 6 per group). **p < 0.01, log-rank
(Mantel–Cox) test. c Viral RNA copies in sera were measured at the indicated time points by qRT-PCR assay (n= 5 per time point). d ZIKV RNA
recovered from the brain, lung, liver, kidney, spleen, testes, small intestine, and rectum were quantified by qRT-PCR (n= 4 per group). e The size and
weight of the testes from uninfected or ZIKV anally-infected Ifnar1−/− mice were measured at 15 dpi (n= 6, mock; n= 8, ZIKV). Scale bar= 0.5 cm.
****p < 0.0001, unpaired Student’s t-test. f RNA in situ hybridization of organ tissues from mock-infected or ZIKV anally-infected Ifnar1−/− mice with a
ZIKV-specific probe at 5 dpi. Scale bar represents 100 μm. The data in (f) are representative of two independent experiments with at least two animals
per group
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We further validated the above result in immuno-
competent C57 mice. Upon i.a. infection, ZIKV RNA
could be detected in the blood of mice at 1 and 2 dpi, but
not at 3 dpi (Fig. S8a). Furthermore, ZIKV could be found
in all inspected organs except for the brain. The highest
burden of ZIKV was seen in the spleen, rectum, and anal
canal at 1 dpi (Fig. S8b). The above results show that i.a.
inoculation of ZIKV in immunocompetent and Ifnar1−/−
mice leads to systemic infection of almost all organ sys-
tems, with resulting testicular damage and inflammation
in the brain and rectum in Ifnar1−/− mice.
ZIKV infects and triggers innate immune responses in
human colon cells
To profile the specific immune responses triggered by i.
a. infection of mice with ZIKV, we assayed their ZIKV-
specific antibody kinetics. We can see that ZIKV-specific
IgM and IgG antibodies were detected at 7 dpi in mice
infected by the i.a. route (Fig. S9). Furthermore, Luminex
assay showed the upregulated expression of multiple
cytokines and chemokines, including IFN-γ, IP-10, MIG,
IL-13, and IL-12 (Fig. 4a).
To help characterize the innate response to ZIKV in the
anorectal mucosa of humans, we performed infections in
two human colon epithelial cell lines, HT-29 and SW620.
As shown in Fig. S10, ZIKV efficiently infected both
groups. RNA-seq analysis of HT-29 cells revealed that
ZIKV infection caused the upregulation of IFNB and
several innate immune response genes, including
FAM60A, IFI6, DDX58, OAS1, MX1, and IP-10 (Fig. 4b
and Fig. S11a). Gene ontology analysis showed that many
genes associated with antiviral activity or the type I
interferon signaling pathway were upregulated (Fig. 4c),
highlighting the importance of the innate immune
response in the clearance of ZIKV. Interestingly, many
genes related to cell growth and metabolism were
downregulated (Fig. 4d), consistent with the gene
expression profiles seen in ZIKV-infected human skin
cells and neonatal brains4,28. These results were con-
firmed by qRT-PCR analysis, showing upregulated
expression of IFNB, MX1, IP-10, CH25H, ISG15, OASL,
IFITM3, RIG-I, and TRIM21 following ZIKV infection at
24 hpi but not 12 hpi (Fig. 4e and Fig. S11b–g), in
agreement with previous findings in A549 cells29. Inter-
estingly, our analysis also revealed several previously
unidentified ZIKV-induced genes (ZIGs) in human colon
cells, such as FAM60A, BET1L, and LPAR6.
Intra-anal infection of pregnant mice with ZIKV leads to
transplacental transmission and impaired fetal
development
Finally, we examined the possible effects of maternal i.a.
ZIKV infection on the fetus. C57 mice were mated and
the dams were subsequently administered anti-Ifnar1
antibody at E5.5, followed by i.a inoculation with ZIKV at
E6.5 (Fig. 5a). A group was euthanized at E14.5 to mea-
sure viral loads from the organs of the adult mice, the
placenta, or the fetal head. ZIKV RNA was detected in all
tested organs of adult mice, with the highest level found in
the spleen (Fig. 5b). Viral loads in the placenta and head of
the fetus, as measured by qRT-PCR, were particularly
elevated (Fig. 5c, d). Meanwhile, the condition and size of
each fetus was measured at E17.5, with the fetuses from
ZIKV-infected mice noted to be much smaller than those
in the mock-infected group (Fig. 5e, f). ZIKV RNA was
also recovered from placental tissue at E17.5 (Fig. 5g).
These results show that the i.a. infection of pregnant mice
with ZIKV leads to transplacental infection and impaired
development of the fetus.
Discussion
In this study, we examined two separate mouse models
to characterize the infectivity and resulting pathogenesis
of ZIKV infection by the i.a. route, which is the likely
mode of transmission following anal intercourse. Our
results showed that i.a. inoculation leads to ZIKV viremia
and systemic spread in both immunocompetent and
Ifnar1−/− mouse strains. In Ifnar1−/− mice, ZIKV i.a.
infection leads to weight loss, organ inflammation,
including significant testicular damage, and death. In
pregnant C57 mice treated with anti-Ifnar1 antibody, the
viremia following i.a. inoculation of ZIKV also crosses the
placenta, resulting in suppression of fetal growth and
development.
We made the important discovery that ZIKV can be
shed into the stool, even in immunocompetent hosts.
Other reports have found ZIKV in high concentrations in
multiple body fluids and secretions such as saliva, tears,
urine, and semen, with the ability to be transmitted by
close contact or sexual activity9,19,22. While sexual trans-
mission has not been documented for other flavivirus
infections, some members of this family have been
recovered from fecal samples of avian hosts. The RNA of
Tembusu virus was detected in duck feces and cloacal
swabs30,31. Infectious particles of West Nile virus (WNV)
were isolated from oral and cloacal swab samples of dead
birds32. The possibility of fecal-oral transmission of ZIKV
is unknown, however, our detection of ZIKV in human
stool and anal lavage samples does suggest a mechanism
for sexual transmission through anal intercourse. It also
introduces the possibility of using such patient samples as
an additional screening tool for ZIKV diagnosis or epi-
demiological monitoring.
Although there has been only one reported human case
of i.a. transmission to date15, the actual incidence of ZIKV
transmission through anal intercourse could in fact be
quite substantial. Reporting of sexually transmitted
infections in general is notoriously low due to factors such
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as shame, fear, cost, and misinformation33–35. ZIKV
infection itself is often missed in endemic regions because
80% of cases are asymptomatic36. This makes it all the
more likely that silent transmission between sexual part-
ners could be occurring, creating new reservoirs of the
virus even in areas where mosquito-borne transmission is
not prevalent. Our findings underscore the importance of
using condoms to prevent ZIKV transmission in indivi-
duals who engage in anal intercourse, especially since
ZIKV has been detected in seminal fluid for up to
6 months37.
Recently, Haddow et al. showed that both intrarectal
and intravaginal inoculation of monkeys with ZIKV
resulted in a high rate of infection38, which is in agree-
ment with our results. In vitro experiments from our lab
and others demonstrated that colonic cells (Caco-2, HT-
29, and SW620) are susceptible to ZIKV infection39. This
supports our hypothesis that ZIKV infection can be
established in the mucosa of the anorectal canal, which
explains the probable mechanism of infection for the
reported case of male-to-male human ZIKV transmission.
From there, it can spread in the bloodstream and trigger
ZIKV-specific humoral immune responses and sympto-
matic infection, as seen in the single reported human case
(subjective fever, myalgia, headache, lethargy, malaise,
rash, arthritis, and conjunctivitis). In our experiments
with immunocompromised mice, the infection resulted in
extensive viral replication in the blood and multiple
organs, including the brain, small intestine, testes, and
rectum. Moreover, i.a. inoculation of ZIKV in pregnant
mice rendered more susceptible to infection using the
anti-Ifnar1 antibody resulted in transplacental infection
and delayed fetal development. It would be interesting to
investigate whether other flaviviruses could also infect
intestinal cells and be shed in the stool. Future experi-
ments could also more closely examine the
Fig. 4 ZIKV infects and triggers innate immune responses in human colon cells a Expression levels of cytokines and chemokines in sera from
ZIKV anally-infected Ifnar1−/− mice (106 PFU/mouse), analyzed by Luminex assay at 7 dpi. The average expression levels of cytokines from 3 mice are
shown. b Relative expression levels of the 30 innate immune response genes in human colon cells (HT-29) most upregulated by ZIKV infection. The
cells were infected with ZIKV (GZ01 strain, MOI 0.5) for 24 h, and total RNA was extracted and analyzed by RNA-seq. c, d Pathways for the up- (c) or
down- (d) regulated genes enriched by gene ontology pathway analysis. "-" means "negative". e The mRNA expression levels of IFNB, MX1, and IP-10
in ZIKV-infected (GZ01 strain, MOI 1) HT-29 cells were measured by qRT-PCR at the indicated time points. All data are shown as the mean ± SEM.
*p < 0.05, **p < 0.01, unpaired Student’s t-test
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transmissibility of ZIKV in human stool samples. Our
knowledge of the pathogenesis of i.a. ZIKV infection in
humans is currently limited to the single reported case,
and we can only extrapolate from animal models what
might occur in potentially uncontrolled infection in
immunocompromised humans.
In summary, our data characterize the infectivity and
pathogenesis caused by ZIKV i.a. infection using both
Ifnar1−/− and immunocompetent mice. We demon-
strated the particularly high susceptibility of the brain,
testes, and gastrointestinal tissues of Ifnar1−/− mice to
ZIKV infection by this route and that the placenta and
fetus remain a target of infection even in immuno-
competent strains of mice. Interestingly, we showed that
ZIKV RNA can be recovered from the stool, which could
potentially be used as a future tool to diagnose or monitor
for ZIKV infection. This also highlights the importance of
men who are suspected to be carrying ZIKV to avoid
unprotected anal intercourse. This route of ZIKV infec-
tion represents a new field of study for ZIKV-host
pathology, which could impact not only transmission,
but possibly future surveillance of ZIKV.
Materials and Methods
Human serum and stools
Human serum and stools from healthy individuals and
ZIKV-infected patients were collected at the Guangzhou
Eighth People’s Hospital, Guangzhou Medical University.
This study was performed according to the principles of
the Declaration of Helsinki and approved by the
Guangzhou Eighth People’s Hospital, Guangzhou Medical
University, for the protection of human subjects. All the
participants provided written informed consent.
The study was approved by the ethics committee of the
Guangzhou Eighth People’s Hospital (Reference Number
20160264) according to the medical research regulations
of China.
Mice and ethics statement
Ifnar1−/− mice (IFN-α/β receptor deficient) were kindly
provided by Professor Qi-Bin Leng (Institut Pasteur of
Shanghai, Chinese Academy of Sciences, China). C57
mice were purchased from the Vital River Laboratory
(Beijing, China) and bred in our core animal facility. All
animal experiments were performed according to the
Fig. 5 Intra-anal infection of pregnant mice with ZIKV leads to transplacental transmission and impaired fetal development a Illustration of
the experiment. 7–8-week-old C57 mice were mated, and pregnant mice were infected i.a. by ZIKV (106 PFU/mouse) at E6.5 after treatment with anti-
Ifnar1 antibody at E5.5. Mice were euthanized at E14.5 (E6.5-E14.5) or E17.5 (E6.5-E17.5). b–d ZIKV RNA copies recovered at E14.5 (8 dpi) from tissues of
pregnant mice, including the brain, lung, liver, kidney, spleen, small intestine, and rectum (n= 5 per group) (b), or the offspring of 2 representative
pregnant mice including the placenta (c) or the fetal head (d) were quantified by qRT-PCR (n= 9, Mock; n= 14). e, f Condition and length of
individual fetuses at E17.5 (e n= 10 Mock; n= 9 ZIKV; f n= 5 per group). The size of each fetus within the amniotic sac is shown in (e), while
(f) shows the length measured when the placenta and amniotic tissues are removed. Scale bar= 1 cm. g Viral load in the placenta at E17.5 (n= 6 per
group). Offspring in (e–g) were from one representative pregnant mouse. **p < 0.01, ***p < 0.001, ****p < 0.0001, unpaired Student’s t-test
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standard operating protocol (SOP) issued by the Animal
Experiment Committee of the Laboratory Animal Center,
Academy of Military Medical Sciences, China (IACUC-
13-2016-001).
Viruses, cells, and reagents
ZIKV strains GZ01 (GenBank: KU820898), FSS13025
(GenBank: JN860885), and DENV-2 (43 strain, GenBank:
AF204178) were used in this study as mentioned pre-
viously29. BHK-21, HT-29, and SW620 cells were purchased
from ATCC and cultured at 37 °C and 5% CO2 in DMEM,
F12 or RPMI 1640 media, respectively. All media were
supplemented with 10% FBS (ExCell Bio, Jiangsu), 100 units/
ml penicillin, and 100 μg/ml streptomycin. 4G2 monoclonal
antibody (mAb) targeting the ZIKV E protein was produced
as previously described29. Mouse anti-Ifnar1 antibody (clone
MAR1-5A3) was purchased from Leinco Technologies, Inc.
(St. Louis, MO, USA).
Sample collection and real-time quantitative PCR
Feces were collected immediately upon release and
associated with individual mice. Fecal weight was
recorded, and then the sample was suspended in 500
μl DMEM. 200 μl of the fecal suspension was used for
RNA extraction. A volume of 150 μl PBS was used for
anal lavage of each mouse. Total viral RNA isolated
from mouse sera, cell supernatants, anal lavage or
feces was extracted using the EasyPure Viral DNA/
RNA Kit (TransGen Biotech, Beijing). Real-time
quantitative PCR (qRT-PCR) was conducted to mea-
sure viral RNA copies. ZIKV primers were described
previously40.
ZIKV intra-anal infection in mice
Three to four-week-old male Ifnar1−/− mice, C57
pregnant mice, or immunocompetent C57 mice were
infected with ZIKV (strain GZ01/2016 or FSS13025)
through the anal canal. Briefly, mice were inoculated with
virus stock using a sterile animal feeding needle (20 G, 6
cm length, 1 mm diameter ball tip) carefully inserted into
the anal canal to avoid trauma. The anal canal was tilted
upwards for 5–10min to help ensure infection. ZIKV
RNA copies in sera were measured by qRT-PCR as
described previously29. Four mice were euthanized for
tissue microscopy or qRT-PCR analyses of ZIKV infection
in the organs at the indicated time points.
Plaque assay
BHK-21 cells were incubated with samples containing
virus at 37 °C for 1 h. The plate was then washed once
with PBS, and overlay media containing 2% FBS and 1%
low melting temperature agar (Promega) was added for
the plaque assay. Viral plaques were counted at 4 dpi after
staining with crystal violet solution.
In situ hybridization of ZIKV RNA
The assay was performed with an RNAscope 2.5
(Advanced Cell Diagnostics) according to the manu-
facturer’s instructions. Briefly, formalin-fixed paraffin-
embedded (FFPE) tissue samples were deparaffinized for
60min at 60 °C. Peroxidases in the samples were quen-
ched with hydrogen peroxide at room temperature for
10min. Slides were then heated in RNAscope Target
Retrieval Reagents for 15min and incubated in RNAscope
Protease Plus before hybridization with probes for 30min.
The probe targeting ZIKV RNA was designed and syn-
thesized by Advanced Cell Diagnostics (catalog no.
467871). Samples were counterstained with Gill’s hema-
toxylin and visualized with bright-field microscopy.
ELISA assay
Briefly, 100 ng/well of ZIKV E protein was coated onto
an ELISA plate. Mouse sera were diluted with PBS con-
taining 1% BSA and added to the plate for 1 h at 37 °C.
The plate was then washed three times using PBST
and incubated with HRP-conjugated IgG or IgM for 1 h at
37 °C. After washing three times with PBST, the plate was
incubated with TMB solution at 37 °C for 30min. Stop
solution was added to the wells for 3 min, and the OD450
was measured by a microplate reader.
Luminex assay
The Cytokine 20-Plex Mouse Panel (LMC0006M,
Thermo Fisher) and 25-Plex Human Panel (LHC0009,
Thermo Fisher) was used to measure cytokines in mouse
and human sera, respectively, which were diluted with
assay dilution buffer. The assay was conducted using a
Luminex200, and the results were analyzed by Luminex
xPONENT according to the manufacturer’s protocol.
RNA-seq analysis and GO analysis
Total RNA from HT-29 cells infected by ZIKV
(GZ01 strain, MOI 0.5) for 24 h or mock-infected was
isolated and used to analyze global mRNA transcription
by RNA-seq. The Ribo-Zero™ Magnetic Gold Kit (Illu-
mina, MRZG12324) was used to remove ribosomal RNA
from 1 μg of the RNA sample, which was then cleaned by
Agencourt RNAClean XP beads (Beckman Coulter,
A63987). A volume of 5 μl of the eluate was used to create
strand-specific RNA libraries using the NEBNext Ultra
Directional RNA Library Prep Kit for Illumina (NEB,
E7420L) according to the manufacturer’s instructions.
The library quality was evaluated on the Agilent 2100
bioanalyzer and quantified by qPCR using the Universal
KAPA Library Quantification Kit (KAPA Biosystems,
KK4824). Libraries were sequenced on a HiSeq X10
instrument (paired ends 2*150 bp). Genes with a fold
change > 1.2 and p < 0.05 between the ZIKV and mock
groups were labeled as ZIKV-induced genes (ZIG). ZIG
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qRT-PCR primers were obtained from the Primer Bank
(https://pga.mgh.harvard.edu/primerbank/). The mRNA
level of each ZIG was analyzed using SYBR Green qPCR
mix (TransGen Biotech, Beijing). Gene ontology analysis
was performed using the GO enrichment analysis tool
(http://geneontology.org/page/go-enrichment-analysis).
The raw sequence data reported in this paper have been
deposited into the Genome Sequence Archive41 of the
BIG Data Center, Beijing Institute of Genomics (BIG),
Chinese Academy of Sciences, under accession number
CRA000783, which is publicly accessible at http://bigd.
big.ac.cn/gsa.
Immunofluorescence assay (IFA)
HT-29 and SW620 cells were infected with ZIKV for
48 h and were fixed. Slices were blocked at room tem-
perature for 1 h with 2% goat sera, 0.3% Triton X-100, and
5% BSA in PBS. The 4G2 mAb (5 μg/ml) was applied at
room temperature for 1 h, and binding was visualized
using FITC-conjugated secondary antibody. Cell nuclei
were stained with DAPI (Sigma). Slices were imaged by
fluorescence microscopy.
ZIKV intra-anal infection of pregnant mice
Seven to eight-week-old male and female mice were
mated, and the vaginal plugs of female mice were mon-
itored. At E5.5 (embryonic day 5.5), 2 mg/mouse of anti-
Ifnar1 antibody was administered to the pregnant mice to
facilitate viral infection. These mice were then infected
with 106 PFU of the GZ01 strain through the anal canal at
E6.5. The infected mice were euthanized to detect viral
loads in the maternal sera and organs listed in Fig. 5b, as
well as the fetal brain and placenta using qRT-PCR at
E14.5, or to measure fetus sizes and viral loads in the
placenta at E17.5.
Statistical analysis
Data were analyzed by Prism software (GraphPad) or
Microsoft Excel. All data are shown as the mean ± SEM if
not otherwise indicated. For in vivo studies, the figures
show data from a single representative experiment. *p <
0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, unpaired
Student’s t-test.
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